Tekcapital plc Successful Production and Testing of µSaltTM (2511T)
January 04 2017 - 2:00AM
UK Regulatory
TIDMTEK
RNS Number : 2511T
Tekcapital plc
04 January 2017
Dissemination of a Regulatory Announcement that contains inside
information according to REGULATION (EU) No 596/2014 (MAR)
Tekcapital plc
("Tekcapital" or "the Company")
Successful Production and Independent Testing of uSalt(TM)
Tekcapital plc (AIM: TEK), an international provider of
technology and intellectual property services, announces a
successful test-production and independent taste testing of
uSalt(TM) , its proprietary, low-sodium salt product.
Successful Taste Tests
Tekcapital has manufactured test quantities of uSalt(TM) in a
current Good Manufacturing Practice ("cGMP") facility regulated by
the US Food and Drug Administration. Test quantities of uSalt(TM)
were then supplied to several organisations for independent testing
and evaluation. The results of the study indicate that a taste test
of traditional potato chips versus those salted with uSalt(TM) ,
with approximately 40% less sodium than traditional potato chips,
yielded no statistically significant difference in perceived salt
flavour.
Technology Background
In 2016, Tekcapital announced that it acquired US patent
#8,900,650 B1 for low-sodium salt compositions, which has the
potential to enable the commercialisation of a 1:1 replacement for
regular salt in a variety of applications including table-top, dry
snacks such as chips and crisps, popcorn, cereals, and other dry
surface applications that have salt in spice mixes.
Regular 'table salt' is not readily soluble in saliva because of
its high density and large particles size. When regular salt
particles are sprinkled on foods for immediate consumption or
during further processing, they tend to provide low-intensity and
long-lasting spotty salty tastes. The uSalt(TM) technology aims to
deliver an improved dissolution, providing an equally salty taste
as table salt with lower salt concentrations.
This innovative 'microsalt' does not contain substitutes like
calcium, potassium or magnesium salts, which can impart the bitter
taste that is typical of many existing low-sodium salt products.
Furthermore, these nano particles dissolve faster and are tasted
faster by the consumer, thereby allowing for the reduction of the
concentration of salt in dry snacks where salt and spices are
applied to the surface.
Key features of a commercialised version of this salt
preparation would include, but may not be limited to, co-blending
with spices, flavours, colours and flow agents and increasing salt
dispersion while enhancing salt sensation in the mouth.
Market Potential
According to market research firm IBISWorld Inc., sales of table
salt in the United States in 2013 were approximately $598.7
million(1) . Based on the recently completed results from an
independent university test, the Directors believe that its
uSalt(TM) low-sodium technology could enable food companies to
empower consumers to reduce sodium content in topical food
applications without sacrificing taste. Furthermore, the Directors
believe that this will be helpful in enabling individuals to seek
to reduce their sodium consumption to less than or equal to 2,300
mg per day, as recommended in the 2015-2020 Dietary Guidelines for
Americans(2) .
Commenting on the announcement, Clifford M. Gross, Ph.D.,
Executive Chairman of Tekcapital plc, said:
"We are excited to report that we have produced and tested our
natural uSalt(TM) product and have found that it provides a level
of taste similar to traditional salt, but with approximately 40%
less sodium. If widely adopted, we believe that the potential
positive impact to improving the health of consumers could be
significant. We are currently in discussions with a number of
leading companies regarding commercialisation of this exciting new
product and we will update the market in due course."
For further information, please contact:
Tekcapital Plc +1 305 200 3450
Clifford M. Gross, Ph.D. info@tekcapital.com
Allenby Capital Limited (Nominated
Adviser & Joint Broker) +44 (0)20 3328 5656
Jeremy Porter / Alex Brearley
Optiva Securities Limited (Joint
Broker) +44 (0) 20 3137 1904
Jeremy King / Vishal Balasingham jeremy.king@optivasecurities.com
Walbrook PR Ltd +44 (0) 20 7933 8780
Paul Cornelius / Helen Cresswell tekcapital@walbrookpr.com
/ Sam Allen
Notes
----------------------------------------------------
1. http://www.prweb.com/releases/2013/8/prweb11061887.htm
2.
http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/ucm494732.htm#ftn9
Tekcapital plc - The World's Largest University Network for Open
Innovation
Tekcapital helps clients profit from new, university-developed
intellectual properties. With our proprietary discovery search
engine, linked to 4,500+ universities in 160 countries, coupled
with expert scientific review, we provide a turn-key service to
make it easy for clients to find and acquire the IP, analytics and
technology transfer professionals they need to create a competitive
advantage. Tekcapital plc is listed on the AIM market of the London
Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in
the UK. For more information, please visit www.tekcapital.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
UPDUGUWWGUPMGMW
(END) Dow Jones Newswires
January 04, 2017 02:00 ET (07:00 GMT)
Tekcapital (LSE:TEK)
Historical Stock Chart
From Apr 2024 to May 2024
Tekcapital (LSE:TEK)
Historical Stock Chart
From May 2023 to May 2024